Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study.

Cancer Sci · 2020 · PMC7004519 · PMID 31789476

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although median OS was 4.9 months with nal‐IRI monotherapy versus 4.2 months with 5‐FU/LV (HR = 0.99; P = .942), this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.